The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis.

Humans Male Mental Disorders / epidemiology Prevalence Smoking Cessation Tobacco Use Disorder / complications Varenicline
Bipolar disorder Major depressive disorder Neuroscience Nicotine dependence Prevalence Psychiatry Schizophrenia Smoking cessation Tobacco use disorder Treatment

Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
01 2022
Historique:
received: 14 12 2020
revised: 21 11 2021
accepted: 22 11 2021
pubmed: 29 11 2021
medline: 3 3 2022
entrez: 28 11 2021
Statut: ppublish

Résumé

The prevalence, correlates, and management of tobacco use disorder (TUD) or nicotine dependence (ND) among people with severe mental illness (SMI), namely schizophrenia, bipolar disorder (BD), and major depressive disorder (MDD), remain unclear. Therefore, a systematic review and meta-analysis was conducted. Electronic databases were systematically searched from inception to July 12, 2020, for observational studies documenting the prevalence, odds, and correlates of TUD/ND among people with SMI; randomized controlled trials (RCTs) informing the management of TUD/ND in people with SMI were also included. Random-effects meta-analyses were conducted. Sources of heterogeneity were explored. Nineteen observational studies, including 7527 participants with SMI met inclusion criteria. TUD/ND co-occurred in 33.4-65% of people with SMI. Rates were higher among males. While bupropion and varenicline represent promising treatment opportunities for schizophrenia with TUD/ND, non-pharmacological interventions require further research, mainly for people with primary mood disorders. TUD/ND represent prevalent co-occurring conditions among people with SMI. Further well-designed RCTs are warranted to inform their management.

Identifiants

DOI: 10.1016/j.neubiorev.2021.11.039 PMID: 34838527
pubmed: 34838527
pii: S0149-7634(21)00533-9
doi: 10.1016/j.neubiorev.2021.11.039
pii:
doi:

Substances chimiques

Varenicline W6HS99O8ZO

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

289-303

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Michele Fornaro (M)

Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy. Electronic address: dott.fornaro@gmail.com.

Andre F Carvalho (AF)

Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Vic., Australia. Electronic address: andrefc7@hotmail.com.

Michele De Prisco (M)

Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy. Electronic address: deprisco.michele@gmail.com.

Anna Maria Mondin (AM)

Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy. Electronic address: annamondin90@gmail.com.

Martina Billeci (M)

Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy. Electronic address: martina.bi@hotmail.it.

Peter Selby (P)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Addiction & Mental Health (CAMH), Toronto, ON, Canada; Department of Family and Community Medicine, University of Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Electronic address: peter.selby@camh.ca.

Felice Iasevoli (F)

Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy. Electronic address: felix_ias@hotmail.com.

Michael Berk (M)

Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia; Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia. Electronic address: michael.berk@deakin.edu.au.

David Jonathan Castle (DJ)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Addiction & Mental Health (CAMH), Toronto, ON, Canada. Electronic address: David.castle@camh.ca.

Andrea de Bartolomeis (A)

Section of Psychiatry - Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy; Chair Staff for Health Education and Sustainable Development, UNESCO, Naples, Italy. Electronic address: andrea.debartolomeis@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The prevalence, odds, predictors, and...
questionsmedicales.fr › Troubles mentaux › The prevalence, odds, predictors, and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Prévalence › The prevalence, odds, predictors, and...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Comportement en matière de santé › Arrêter de fumer › The prevalence, odds, predictors, and...
questionsmedicales.fr › Troubles mentaux › Troubles liés à une substance › Trouble lié au tabagisme › The prevalence, odds, predictors, and...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Quinoxalines › Varénicline › The prevalence, odds, predictors, and...